10 Mini Oral LORIS: A multicentre, randomised phase III trial of standard surgery versus active monitoring in women with newly diagnosed low risk ductal carcinoma in situ (DCIS): 5 year follow up. ISRCTN: 27544579. Currently in long term follow up. Sponsor: University Birmingham

LORIS TMG and Investigators; M.G. Wallis; J. van de Wiel; P. Fairbrother; D. Rea

doi:10.1016/j.ejca.2026.116309

10 Mini Oral LORIS: A multicentre, randomised phase III trial of standard surgery versus active monitoring in women with newly diagnosed low risk ductal carcinoma in situ (DCIS): 5 year follow up. ISRCTN: 27544579. Currently in long term follow up. Sponsor: University Birmingham

LORIS TMG and Investigators
, M.G. Wallis
, J. van de Wiel
, P. Fairbrother
, D. Rea

Cancer Research UK Clinical Trials Unit

Research output: Contribution to journal › Abstract › peer-review

Original language	English
Article number	116309
Pages (from-to)	17-17
Number of pages	1
Journal	European Journal of Cancer
Volume	237
Issue number	Supplement 1
DOIs	https://doi.org/10.1016/j.ejca.2026.116309
Publication status	Published - 27 Mar 2026
Event	15th European Breast Cancer Conference - Barcelona, Spain Duration: 25 Mar 2026 → 27 Mar 2026

Access to Document

10.1016/j.ejca.2026.116309

Cite this

LORIS TMG and Investigators, Wallis, M. G., de Wiel, J. V., Fairbrother, P., & Rea, D. (2026). 10 Mini Oral LORIS: A multicentre, randomised phase III trial of standard surgery versus active monitoring in women with newly diagnosed low risk ductal carcinoma in situ (DCIS): 5 year follow up. ISRCTN: 27544579. Currently in long term follow up. Sponsor: University Birmingham. European Journal of Cancer , 237(Supplement 1), 17-17. Article 116309. https://doi.org/10.1016/j.ejca.2026.116309

LORIS TMG and Investigators ; Wallis, M.G. ; de Wiel, J. van et al. / 10 Mini Oral LORIS: A multicentre, randomised phase III trial of standard surgery versus active monitoring in women with newly diagnosed low risk ductal carcinoma in situ (DCIS): 5 year follow up. ISRCTN: 27544579. Currently in long term follow up. Sponsor: University Birmingham. In: European Journal of Cancer . 2026 ; Vol. 237, No. Supplement 1. pp. 17-17.

@article{58e609094681465ba14432a63b77d75f,

title = "10 Mini Oral LORIS: A multicentre, randomised phase III trial of standard surgery versus active monitoring in women with newly diagnosed low risk ductal carcinoma in situ (DCIS): 5 year follow up. ISRCTN: 27544579. Currently in long term follow up. Sponsor: University Birmingham",

author = "\{LORIS TMG and Investigators\} and M.G. Wallis and \{de Wiel\}, \{J. van\} and P. Fairbrother and D. Rea",

year = "2026",

month = mar,

day = "27",

doi = "10.1016/j.ejca.2026.116309",

language = "English",

volume = "237",

pages = "17--17",

journal = "European Journal of Cancer ",

issn = "0959-8049",

publisher = "Elsevier",

number = "Supplement 1",

note = "15th European Breast Cancer Conference, EBCC-15 ; Conference date: 25-03-2026 Through 27-03-2026",

}

LORIS TMG and Investigators, Wallis, MG, de Wiel, JV, Fairbrother, P & Rea, D 2026, '10 Mini Oral LORIS: A multicentre, randomised phase III trial of standard surgery versus active monitoring in women with newly diagnosed low risk ductal carcinoma in situ (DCIS): 5 year follow up. ISRCTN: 27544579. Currently in long term follow up. Sponsor: University Birmingham', European Journal of Cancer , vol. 237, no. Supplement 1, 116309, pp. 17-17. https://doi.org/10.1016/j.ejca.2026.116309

10 Mini Oral LORIS: A multicentre, randomised phase III trial of standard surgery versus active monitoring in women with newly diagnosed low risk ductal carcinoma in situ (DCIS): 5 year follow up. ISRCTN: 27544579. Currently in long term follow up. Sponsor: University Birmingham. / LORIS TMG and Investigators; Wallis, M.G.; de Wiel, J. van et al.
In: European Journal of Cancer , Vol. 237, No. Supplement 1, 116309, 27.03.2026, p. 17-17.

Research output: Contribution to journal › Abstract › peer-review

TY - JOUR

T1 - 10 Mini Oral LORIS: A multicentre, randomised phase III trial of standard surgery versus active monitoring in women with newly diagnosed low risk ductal carcinoma in situ (DCIS): 5 year follow up. ISRCTN: 27544579. Currently in long term follow up. Sponsor: University Birmingham

AU - LORIS TMG and Investigators

AU - Wallis, M.G.

AU - de Wiel, J. van

AU - Fairbrother, P.

AU - Rea, D.

PY - 2026/3/27

Y1 - 2026/3/27

U2 - 10.1016/j.ejca.2026.116309

DO - 10.1016/j.ejca.2026.116309

M3 - Abstract

SN - 0959-8049

VL - 237

SP - 17

EP - 17

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - Supplement 1

M1 - 116309

T2 - 15th European Breast Cancer Conference

Y2 - 25 March 2026 through 27 March 2026

ER -

LORIS TMG and Investigators, Wallis MG, de Wiel JV, Fairbrother P, Rea D. 10 Mini Oral LORIS: A multicentre, randomised phase III trial of standard surgery versus active monitoring in women with newly diagnosed low risk ductal carcinoma in situ (DCIS): 5 year follow up. ISRCTN: 27544579. Currently in long term follow up. Sponsor: University Birmingham. European Journal of Cancer . 2026 Mar 27;237(Supplement 1):17-17. 116309. doi: 10.1016/j.ejca.2026.116309